Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122454453 | 12245445 | 3 | F | 2014 | 20160715 | 20160407 | 20160721 | EXP | US-PFIZER INC-2016199456 | PFIZER | 34.00 | YR | F | Y | 0.00000 | 20160721 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122454453 | 12245445 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK, AS DIRECTED | U | 20702 | FILM-COATED TABLET | ||||||||
| 122454453 | 12245445 | 2 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | UNK, 1X/DAY (ONE A DAY) | U | 20702 | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122454453 | 12245445 | 2 | Blood cholesterol abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122454453 | 12245445 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122454453 | 12245445 | Emotional distress | |
| 122454453 | 12245445 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122454453 | 12245445 | 1 | 2013 | 2015 | 0 | |
| 122454453 | 12245445 | 2 | 2015 | 0 |